Topic guide
Articles and reference material connected to this topic, organised for clear reading.
Reading path
Two posters presented at ATS 2025 offered data on Rein Therapeutics’ novel peptide LTI-03’s potential clinical value for idiopathic pulmonary fibrosis patients. RT’s Three Key Takeaways: Dual Mechanism of Acti…
Read guide →Breath capacity is one of the key factors determining athletic achievements. The lungs' ability to effectively transport oxygen and remove carbon dioxide directly affects endurance, muscle recovery, and overal…
Read guide →A novel peptide designed by University of California, Irvine researchers has been found to suppress the damaging lung inflammation seen in acute respiratory distress syndrome (ARDS). Their study, which appears…
Read guide →A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat the uncontrolled secretion of mucins in the airways, which causes potentially life-thre…
Read guide →Abstract Various lung diseases endanger people’s health. Side effects and pharmaceutical resistance complicate the treatment of acute lung injury, pulmonary fibrosis, and lung cancer, necessitating the develop…
Read guide →Emphysema is a progressive, debilitating lung disease in which the lung's breathing sacs, or alveoli, enlarge, get thinner, and eventually are destroyed as the cells die off. It can be fatal, and there is curr…
Read guide →Skip to main content Skip to article View PDF Under a Creative Commons license Open access Abstract Purpose of Review: Idiopathic pulmonary fibrosis (IPF) is chronic interstitial pneumonia with an unclear etio…
Read guide →The findings of preclinical studies suggest that the M10 peptide may help protect against fibrotic damage in patients with systemic sclerosis, and particularly in those who develop interstitial lung diseases (…
Read guide →